ShEEP Request for CTL ImmunoSpot S6 Universal Analyzer
ShEEP 请求 CTL ImmunoSpot S6 通用分析仪
基本信息
- 批准号:9795713
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2019-09-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntineoplastic AgentsAppointmentAreaArthritisB-LymphocytesBiological AssayCancer CenterCarcinomaCell CommunicationCellsCellular biologyChronicChronic DiseaseCitiesColorCommunitiesComplexCost of IllnessCytotoxic T-LymphocytesDefense MechanismsDegenerative polyarthritisDetectionDevelopmentDiseaseDisease ProgressionFlow CytometryFundingFutureGrantHealth SciencesHeart DiseasesHepatitisHeterogeneityImage AnalysisImmuneImmunologic MarkersImmunologic MonitoringImmunologicsImmunologyImmunooncologyInfectionInfiltrationInflammationInflammatoryInflammatory Bowel DiseasesInstitutionLeadershipMaintenanceMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMeasuresMediatingMedical centerMethodologyMicroscopicMinorMolecularMonitorNatureNon-Insulin-Dependent Diabetes MellitusObesityOklahomaPancreatitisPathologicPeer ReviewPerformancePeripheral Blood Mononuclear CellPlayPreventiveReaderResearchResearch ActivityResearch PersonnelResourcesRoleSample SizeScientistSheepSurveysT-LymphocyteTechnologyTimeTissuesUnited StatesUnited States National Institutes of HealthUniversitiesVeteransantigen-specific T cellsbasecareercell typecellular targetingcytokinedesigndrug developmentenzyme linked immunospot assayflexibilityinstrumentinterestmacrophageparticlepreventranpirnaseresearch facilitytooltumor
项目摘要
We are requesting funds to purchase a CTL ImmunoSpot® S6 Universal Analyzer. This instrument
allows investigators primarily to perform multi-color ELISPOT analysis along with other cell-
based applications. Currently, neither the research facility at the Oklahoma City VA Medical
Center (OKC VAMC) nor the affiliated University of Oklahoma Health Sciences Center has
this high-end ELISPOT analyzer. It is well known that immune cells play a critical role in many
diseases including cancer. It is now becoming evident that changes in immune cell heterogeneity
potentially impacts either positively or negatively on the disease progression. However, in the past
only limited technology allowed investigators to study heterogeneity of immune cells, immune
cells interaction with other cell types and their molecular impact in the tissue microenvironment
and more so, immunological markers interface in tissue microenvironment and systemically.
Immune monitoring is complex and better understanding requires multiplexing. CTL
ImmunoSpot® S6 Universal Analyzer permit multicolor T and B cell fluorospot analysis,
live/dead PBMC counting, and much more. This is an attractive alternative to flow cytometry
analysis. CTL ImmunoSpot® S6 Universal Analyzer also allows investigators for other
applications at the microscopic (single cells and subcellular particles) as well as the macroscopic
level (colonies and Plaques). The primary field of application for CTL ImmunoSpot® S6 Universal
Analyzer has been multi-color ELISPOT analysis. CTL employs a technology specifically
designed to avoid excitation cross-contamination, enabling the accurate detection of up to eight
analyte co-expressing cells, including polyfunctional T cells. In addition, image analysis-based
multi-parameter analysis of cells with CTL ImmunoSpot® S6 Universal Analyzer can be useful
with both adherent or non-adherent cells alike, and the sample size for analysis can be as low as
one cell.
A survey of all VA researchers at OKC VAMC showed over 80% of the researchers are potentially
interested to use CTL ImmunoSpot® S6 Universal Analyzer to study the modulation of antigen-
specific T cell induction and activation in their research. This instrument will be used by six major
users who have VA Merit grants funded or pending. We also anticipate that researchers at other
VA centers will use this instrument.
我们正在申请资金购买CTL ImmunoSpot® S6通用分析仪。本文书
允许研究人员主要进行多色ELISPOT分析,沿着其他细胞,
基于应用程序。目前,无论是在俄克拉荷马州城市退伍军人医疗研究机构
中心(OKC VAMC)也没有附属的俄克拉荷马州健康科学中心大学
这台高端ELISPOT分析仪众所周知,免疫细胞在许多疾病中起着关键作用。
包括癌症在内的疾病。现在越来越明显的是,免疫细胞异质性的变化
潜在地对疾病进展产生积极或消极的影响。但过去
只有有限的技术才能让研究人员研究免疫细胞的异质性,免疫细胞,
细胞与其他细胞类型的相互作用及其在组织微环境中的分子影响
更重要的是,免疫标记物在组织微环境中和系统地相互作用。
免疫监测是复杂的,更好的理解需要多路复用。CTL
ImmunoSpot® S6通用分析仪可进行MTT和B细胞荧光斑点分析,
活/死PBMC计数,以及更多。这是一个有吸引力的替代流式细胞术
分析. CTL ImmunoSpot® S6通用分析仪还允许研究者进行其他
应用在微观(单细胞和亚细胞颗粒)以及宏观
水平(菌落和噬菌斑)。CTL ImmunoSpot® S6 Universal的主要应用领域
分析仪已进行多色ELISPOT分析。CTL采用了一种技术,
旨在避免激发交叉污染,能够准确检测多达八个
分析物共表达细胞,包括多功能T细胞。此外,基于图像分析的
使用CTL ImmunoSpot® S6通用分析仪进行细胞的多参数分析是有用的
粘附或非粘附细胞都一样,并且用于分析的样品大小可以低至
一个细胞。
一项对OKC VAMC所有VA研究人员的调查显示,超过80%的研究人员可能
有兴趣使用CTL ImmunoSpot® S6通用分析仪研究抗原的调节-
特异性T细胞诱导和活化。该仪器将用于六个主要的
谁拥有VA优异奖赠款资助或待定的用户。我们还预计,研究人员在其他
VA中心将使用该仪器。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chinthalapally V. Rao其他文献
Mutational disparities in colorectal cancers of White Americans, Alabama African Americans, And Oklahoma American Indians
白种美国人、阿拉巴马州非裔美国人和俄克拉何马州美洲印第安人结直肠癌的突变差异
- DOI:
10.1038/s41698-024-00782-9 - 发表时间:
2024-12-23 - 期刊:
- 影响因子:8.000
- 作者:
Hiroshi Y. Yamada;Madhusmita Rout;Chao Xu;Philip H. O’Neill;Farrukh Afaq;Katherine T. Morris;Dharambir K. Sanghera;Upender Manne;Chinthalapally V. Rao - 通讯作者:
Chinthalapally V. Rao
Targeting PGE<sub>2</sub>/IL-23 Nexus in TME for CRC Prevention and Treatment
- DOI:
10.1016/j.canlet.2023.216553 - 发表时间:
2024-01-28 - 期刊:
- 影响因子:
- 作者:
Chinthalapally V. Rao - 通讯作者:
Chinthalapally V. Rao
Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer
- DOI:
10.1007/s10555-011-9311-2 - 发表时间:
2011-10-21 - 期刊:
- 影响因子:8.700
- 作者:
Naveena B. Janakiram;Altaf Mohammed;Chinthalapally V. Rao - 通讯作者:
Chinthalapally V. Rao
Chinthalapally V. Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chinthalapally V. Rao', 18)}}的其他基金
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS. TASK ORDER TITLE: URINARY BLADDER CANCER PREVENTIO
预防癌症临床前药物开发计划:临床前疗效和终点生物标志物。
- 批准号:
10269136 - 财政年份:2020
- 资助金额:
-- - 项目类别:
EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.
评估两类不同类型的化合物(STAT3 抑制剂和 Serms)预防膀胱癌的作用。
- 批准号:
10674662 - 财政年份:2020
- 资助金额:
-- - 项目类别:
EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.
评估两类不同类型的化合物(STAT3 抑制剂和 Serms)预防膀胱癌的作用。
- 批准号:
10269139 - 财政年份:2020
- 资助金额:
-- - 项目类别:
PREVENTION OF CRC BY iNOS AND COX-2 SELECTIVE INHIBITORS
通过 iNOS 和 COX-2 选择性抑制剂预防 CRC
- 批准号:
6815750 - 财政年份:2004
- 资助金额:
-- - 项目类别:
PREVENTION OF CRC BY iNOS AND COX-2 SELECTIVE INHIBITORS
通过 iNOS 和 COX-2 选择性抑制剂预防 CRC
- 批准号:
6952292 - 财政年份:2004
- 资助金额:
-- - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
-- - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
-- - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
-- - 项目类别: